WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

*Dasari Pavani, Bollam Prathyusha and Goulikar Sai Nishanth

ABSTRACT

Objective: The main objective of the study is to assess the safety and tolerability of high intensity atorvastatin in various cardiovascular diseases. Methodology: A prospecive observational study was conducted in the cardiology department (in patient) of a tertiary care hospital. The data was collected from the in-patient department after considering inclusion and exclusion criteria for a period of 6 months and a total of 120 patients were analyzed with data collection form by interviewing the patient’s about the socio -demographic questionnaire , for every 3 months the patient’s blood samples are collected to observe lipid values. Statistical tools like Chi-Square test and T-test were applied to the data by using SPSS software. Result: Among 120 patients, males are more predominant than females. Patient’s between the age group of 40 and 60 years are more prone to CVD. According to our data, 12.5% of patients are smokers, 30% are alcoholics and 12.5% patients are both alcoholics and smokers 25% of patients had a family history of HTN, 10 % of patients had a family history of DM and Heart disease and 7.5% of patients had a family history of Hypertension with Heart disease, 7.5% 0f patients had a family history of Hypertension with DM. Among 120 patients, 72 (60%) patients had a past history of Hypertension and DM. Among 120 patients, 25% of patients have IWMI, 25% of patients have AWMI, 12.5% of patients have NSTEMI, 2.5% patients have RHD, 15% patients have AIS, 10% patients have TIA, 10% patients have unstable angina. Among these patients, patients with IWMI(30) AND AWMI(30)were more common.40mgdose has been given to 54(45%) patients and 80mg dose has been given to 66(55%) patients. Conclusion: High intensity atorvastatin therapy was given for a period of 6 months in120 patients. High intensity atorvastatin is generally well tolerated in adults in both the 40mg and 80mg doses who are diagnosed with various types of CVD. The ADR of atorvastatin are well managed and are not severe and no one has been withdrawn from the therapy. The overall survival rate of the therapy is 100%. Thus, high intensity atorvastatin is safe and well tolerated.